BioCentury | May 3, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: April 2018

...Intelligence; BioCentury Archives Indication Target Description Company or Institution Notes Therapeutic targets Cancer Breast cancer Platelet derived growth factor CC (PDGFCC)...
BioCentury | Apr 18, 2018
Distillery Therapeutics

Cancer

...alone. Next steps could include testing PDGFCC inhibitors in additional models of breast cancer. TARGET/MARKER/PATHWAY: Platelet derived growth factor CC (PDGFCC)...
...online March 12, 2018 doi:10.1038/nm.4494 CONTACT: Kristian Pietras, Lund University, Lund, Sweden email: kristian.pietras@med.lu.se Chris Lieu tamoxifen Lund University Platelet derived growth factor CC (PDGFCC) Breast...
BioCentury | Jul 1, 2010
Distillery Therapeutics

Indication: Ophthalmic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Ophthalmic disease Choroidal neovascularization (CNV); retinopathy of prematurity Platelet-derived growth factor CC (PDGFCC) Mouse studies suggest that inhibiting PDGFCC could help treat CNV and retinopathy of...
Items per page:
1 - 3 of 3